Thermo Fisher Scientific (NYSE:TMO) Price Target Increased to $575.00 by Analysts at Citigroup

Thermo Fisher Scientific (NYSE:TMO – Free Report) had its target price increased by Citigroup from $530.00 to $575.00 in a report released on Monday, Benzinga reports. Citigroup currently has a buy rating on the medical research company’s stock. A number of other research analysts also recently commented on the company. Wells Fargo & Company raised […]

Leave a Reply

Your email address will not be published.

Previous post HP (NYSE:HPQ) Raised to “Outperform” at Evercore ISI
Next post Holly Energy Partners (NYSE:HEP) Research Coverage Started at StockNews.com